The evolving landscape of tissue‐agnostic therapies in precision oncologyVivek Subbiah, Razelle Kurzrock, Mohamed A. Gouda et al.|CA A Cancer Journal for Clinicians|2024Cited by 68
Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlusVictoria Atkinson, Michele Del Vecchio, Caroline Robert et al.|European Journal of Cancer|2022Cited by 30
Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event (AE) management algorithm in patients (pts) treated with adjuvant dabrafenib + trametinib (dab + tram): Primary results of COMBI-APlus.Victoria Atkinson, Michele Del Vecchio, Caroline Robert et al.|Journal of Clinical Oncology|2021Cited by 9